- Home
- DHY vs BTMD Comparison
DHY vs BTMD Comparison
Compare DHY & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHY
- BTMD
- Stock Information
- Founded
- DHY 1998
- BTMD 2012
- Country
- DHY United States
- BTMD United States
- Employees
- DHY N/A
- BTMD N/A
- Industry
- DHY Finance/Investors Services
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- DHY Finance
- BTMD Health Care
- Exchange
- DHY Nasdaq
- BTMD Nasdaq
- Market Cap
- DHY 224.6M
- BTMD 198.2M
- IPO Year
- DHY N/A
- BTMD N/A
- Fundamental
- Price
- DHY $2.13
- BTMD $5.67
- Analyst Decision
- DHY
- BTMD Strong Buy
- Analyst Count
- DHY 0
- BTMD 5
- Target Price
- DHY N/A
- BTMD $9.11
- AVG Volume (30 Days)
- DHY 569.1K
- BTMD 112.3K
- Earning Date
- DHY 01-01-0001
- BTMD 11-12-2024
- Dividend Yield
- DHY 9.10%
- BTMD N/A
- EPS Growth
- DHY N/A
- BTMD N/A
- EPS
- DHY N/A
- BTMD 0.21
- Revenue
- DHY N/A
- BTMD $193,060,000.00
- Revenue This Year
- DHY N/A
- BTMD $9.22
- Revenue Next Year
- DHY N/A
- BTMD $14.46
- P/E Ratio
- DHY N/A
- BTMD $26.63
- Revenue Growth
- DHY N/A
- BTMD 4.84
- 52 Week Low
- DHY $1.77
- BTMD $3.65
- 52 Week High
- DHY $2.08
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- DHY 38.17
- BTMD 42.22
- Support Level
- DHY $2.12
- BTMD $5.46
- Resistance Level
- DHY $2.19
- BTMD $6.36
- Average True Range (ATR)
- DHY 0.02
- BTMD 0.30
- MACD
- DHY -0.00
- BTMD -0.06
- Stochastic Oscillator
- DHY 7.14
- BTMD 23.33
About DHY Credit Suisse High Yield Bond Fund
Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company with the objective to seek high current income and capital appreciation as a secondary objective.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.